InsiderClue
Stocks · Health care · Services-Medical Laboratories

EXAGEN INC.

XGN Clue Score42
United States Fiscal year ends December CIK 0001274737
$8.42 +3.06% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $8.42 −32.42% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 19 Sep 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Revenue32.4Operating income−4.9Net income−8.0Fiscal year 2019Revenue40.4 +24.5%Operating income−9.3Net income−12.0Fiscal year 2020Revenue42.0 +3.9%Operating income−15.2Net income−16.7EPS, diluted−1.32Fiscal year 2021Revenue48.3 +15.1%Operating income−24.1Net income−26.9EPS, diluted−1.68Fiscal year 2022Revenue45.6 −5.7%Operating income−46.1Net income−47.4EPS, diluted−2.77Fiscal year 2023Revenue52.5 +15.3%Operating income−22.8Net income−23.7EPS, diluted−1.34Fiscal year 2024Revenue55.6 +5.9%Operating income−13.6Net income−15.1EPS, diluted−0.83Fiscal year 2025Revenue66.6 +19.7%Operating income−14.1Net income−20.0EPS, diluted−0.93
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 32.4 40.4 42.0 48.3 45.6 52.5 55.6 66.6
Growth +24.5% +3.9% +15.1% −5.7% +15.3% +5.9% +19.7%
Operating income −4.9 −9.3 −15.2 −24.1 −46.1 −22.8 −13.6 −14.1
Net income −8.0 −12.0 −16.7 −26.9 −47.4 −23.7 −15.1 −20.0
Growth
EPS, diluted n/a n/a −1.32 −1.68 −2.77 −1.34 −0.83 −0.93
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2018Operating margin−15.0%Net margin−24.7%Free cash flow margin−29.3%Fiscal year 2019Operating margin−23.0%Net margin−29.8%Free cash flow margin−25.0%Fiscal year 2020Operating margin−36.2%Net margin−39.8%Free cash flow margin−34.6%Fiscal year 2021Operating margin−49.8%Net margin−55.6%Free cash flow margin−46.9%Fiscal year 2022Operating margin−101.1%Net margin−104.0%Free cash flow margin−80.0%Fiscal year 2023Gross margin56.1%Operating margin−43.5%Net margin−45.1%Free cash flow margin−29.1%Fiscal year 2024Gross margin59.5%Operating margin−24.5%Net margin−27.2%Free cash flow margin−24.8%Fiscal year 2025Gross margin58.3%Operating margin−21.1%Net margin−30.0%Free cash flow margin−21.4%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a n/a n/a 56.1% 59.5% 58.3%
Operating margin −15.0% −23.0% −36.2% −49.8% −101.1% −43.5% −24.5% −21.1%
Net margin −24.7% −29.8% −39.8% −55.6% −104.0% −45.1% −27.2% −30.0%
Free cash flow margin −29.3% −25.0% −34.6% −46.9% −80.0% −29.1% −24.8% −21.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow−9.3Capital expenditure−0.2Free cash flow−9.5Fiscal year 2019Operating cash flow−9.7Capital expenditure−0.4Free cash flow−10.1Fiscal year 2020Operating cash flow−14.1Capital expenditure−0.5Free cash flow−14.5Fiscal year 2021Operating cash flow−20.3Capital expenditure−2.4Free cash flow−22.6Fiscal year 2022Operating cash flow−32.1Capital expenditure−4.3Free cash flow−36.5Fiscal year 2023Operating cash flow−14.5Capital expenditure−0.8Free cash flow−15.3Fiscal year 2024Operating cash flow−13.3Capital expenditure−0.5Free cash flow−13.8Fiscal year 2025Operating cash flow−13.6Capital expenditure−0.6Free cash flow−14.3
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −9.3 −9.7 −14.1 −20.3 −32.1 −14.5 −13.3 −13.6
Capital expenditure −0.2 −0.4 −0.5 −2.4 −4.3 −0.8 −0.5 −0.6
Free cash flow −9.5 −10.1 −14.5 −22.6 −36.5 −15.3 −13.8 −14.3
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2018Cash13.2Total debt24.6Net cash (debt)−11.5Shareholders’ equity−112.0Fiscal year 2019Cash72.1Total debt25.9Net cash (debt)46.2Shareholders’ equity55.7Debt to equity0.46Fiscal year 2020Cash57.4Total debt26.7Net cash (debt)30.8Shareholders’ equity41.8Debt to equity0.64Fiscal year 2021Cash99.4Total debt27.5Net cash (debt)72.0Shareholders’ equity84.9Debt to equity0.32Fiscal year 2022Cash62.4Total debt29.0Net cash (debt)33.4Shareholders’ equity42.5Debt to equity0.68Fiscal year 2023Cash36.5Total debt19.5Net cash (debt)17.0Shareholders’ equity22.7Debt to equity0.86Fiscal year 2024Cash22.0Total debt20.2Net cash (debt)1.8Shareholders’ equity9.5Debt to equity2.12Fiscal year 2025Cash32.2Total debt22.9Net cash (debt)9.3Shareholders’ equity17.4Debt to equity1.31
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 13.2 72.1 57.4 99.4 62.4 36.5 22.0 32.2
Total debt 24.6 25.9 26.7 27.5 29.0 19.5 20.2 22.9
Net cash (debt) −11.5 46.2 30.8 72.0 33.4 17.0 1.8 9.3
Shareholders’ equity −112.0 55.7 41.8 84.9 42.5 22.7 9.5 17.4
Debt to equity n/a 0.46 0.64 0.32 0.68 0.86 2.12 1.31

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−9.3 −9.7 −14.1 −20.3 −32.1 −14.5 −13.3 −13.6
Growth
0.6 0.6 0.5 0.9 1.6 2.2 1.7 2.1
Investment
−0.2 −0.4 −0.5 −2.4 −4.3 −0.8 −0.5 −0.6
calc −9.5 −10.1 −14.5 −22.6 −36.5 −15.3 −13.8 −14.3
Growth
calc n/a n/a −1.15 −1.42 −2.13 −0.86 −0.76 −0.66
−0.2 −0.1 −0.5 −2.4 −4.3 −0.8 −0.5 −0.6
Financing
11.4 68.7 −0.1 64.7 −0.5 −10.6 −0.7 24.4

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.